1. Home
  2. FGBI vs ARMP Comparison

FGBI vs ARMP Comparison

Compare FGBI & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGBI
  • ARMP
  • Stock Information
  • Founded
  • FGBI 1934
  • ARMP N/A
  • Country
  • FGBI United States
  • ARMP United States
  • Employees
  • FGBI N/A
  • ARMP N/A
  • Industry
  • FGBI Savings Institutions
  • ARMP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • FGBI Finance
  • ARMP Health Care
  • Exchange
  • FGBI Nasdaq
  • ARMP Nasdaq
  • Market Cap
  • FGBI 122.8M
  • ARMP 125.7M
  • IPO Year
  • FGBI N/A
  • ARMP N/A
  • Fundamental
  • Price
  • FGBI $5.54
  • ARMP $6.73
  • Analyst Decision
  • FGBI
  • ARMP Strong Buy
  • Analyst Count
  • FGBI 0
  • ARMP 1
  • Target Price
  • FGBI N/A
  • ARMP $9.00
  • AVG Volume (30 Days)
  • FGBI 16.0K
  • ARMP 796.6K
  • Earning Date
  • FGBI 10-27-2025
  • ARMP 11-12-2025
  • Dividend Yield
  • FGBI 0.70%
  • ARMP N/A
  • EPS Growth
  • FGBI N/A
  • ARMP N/A
  • EPS
  • FGBI N/A
  • ARMP N/A
  • Revenue
  • FGBI $13,036,000.00
  • ARMP $5,054,000.00
  • Revenue This Year
  • FGBI N/A
  • ARMP $8.43
  • Revenue Next Year
  • FGBI $0.20
  • ARMP N/A
  • P/E Ratio
  • FGBI N/A
  • ARMP N/A
  • Revenue Growth
  • FGBI N/A
  • ARMP N/A
  • 52 Week Low
  • FGBI $5.64
  • ARMP $0.90
  • 52 Week High
  • FGBI $15.25
  • ARMP $16.34
  • Technical
  • Relative Strength Index (RSI)
  • FGBI 25.84
  • ARMP 65.71
  • Support Level
  • FGBI $5.83
  • ARMP $4.65
  • Resistance Level
  • FGBI $6.36
  • ARMP $7.30
  • Average True Range (ATR)
  • FGBI 0.48
  • ARMP 0.72
  • MACD
  • FGBI -0.06
  • ARMP 0.09
  • Stochastic Oscillator
  • FGBI 1.11
  • ARMP 83.40

About FGBI First Guaranty Bancshares Inc.

First Guaranty Bancshares Inc provides personalized commercial banking services to its customers in Louisiana, through several banking facilities. The principal business activity of the company includes attracting deposits and investing it together with funds generated from operations and borrowings insecurities and in lending activities to serve the credit needs of its customer base. The company offers commercial real estate loans, commercial and industrial loans, construction and land development loans, agricultural and farmland loans, and to a lesser extent, consumer and multifamily loans.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

Share on Social Networks: